Hillel Bachrach, MBA

Hillel is the Managing Partner of 20/20 HealthCare Partners, LLC, (20/20 HCP), a global investment entity he founded in 2005. 20/20 HCP has invested in many successful companies including Viztek (acquired by Konica Minolta in 2015), Corindus Vascular Robotics (purchased by Siemens HealthCare in 2019), XR Health, SQZ Biotechnology, Verseau Therapeutics and EnClear Therapies. In addition to Variantyx, Hillel currently serves on the Board of Directors for Zixi and Velocamp. Hillel previously served as president of Odin Medical Technologies, Inc., and helped found UltraSPECT, Ltd., the leader in providing sophisticated dose and procedure time reduction software solutions for nuclear medicine procedures which was sold to Pharmalogic in 2019. Hillel received a BS in electrical engineering from Technion Israeli Institute of Technology and an MBA from the Kellogg Graduate School of Management.